The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
A double blind randomized placebo control trial of levetiracetam in tourette syndrome
Abstract
The objective of this study was to investigate the effectiveness of levetiracetam for the treatment of tics in children with Tourette syndrome (TS). Levetiracetam, an atypical anticonvulsant, has been suggested in open‐label protocols to be an effective tic‐suppressing agent in individuals with TS. A double blind, randomized, placebo‐controlled, cross‐over trial was performed to investigate this medication in children with moderate to moderately‐severe tics. Subjects received, in a randomized sequence, 4‐weeks of levetiracetam (maximum dose 30 mg/kg/day) or placebo, with a 2‐week intervening washout period between cycles. Primary outcome measures included two separate scales from the Yale Global Tic Severity Scale; the Total Tic score and the Total overall score. Measures were assessed at baseline, prior to randomization, on Day 28 (end of Phase 1), on Day 42 (baseline for second phase) and on Day 70 (end of Phase 2). Twenty‐two subjects (21 boys and 1 girl) with TS, mean age 12.2 ± 2.3 years, range 8 to 16 years, participated. A mild reduction in tics occurred during both the levetiracetam and placebo treatment phases. There was no significant difference between treatments and no evidence of sequence or cross‐over effects. In conclusion, Levetiracetam is not more beneficial than placebo in suppressing tics in children with TS. © 2007 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Levetiracetam did not demonstrate a significant benefit to suppressing tics compared with placebo.”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Children's Yale-Brown Obsessive Compulsive Scale: Reliability and Validity
SCAHILL, L., RIDDLE, M. A., McSWIGGIN-HARDIN, M., ORT, S. I., KING, R. A., GOODMAN, W. K., CICCHETTI, D., & LECKMAN, J. F. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199706000-00023 · Cited by 2,045
Cross‐over Trials In Clinical Research
Senn, S. (2002) · doi:10.1002/0470854596 · Cited by 653
A placebo-controlled trial of risperidone in Tourette syndrome
Scahill, L., Leckman, J. F., Schultz, R. T., Katsovich, L., & Peterson, B. S. (2003) · Neurology · doi:10.1212/01.wnl.0000055434.39968.67 · Cited by 362
Research works printed but not linked: 21
- 10.1016/S1474-4422(05)70018-1 · doi:10.1016/s1474-4422(05)70018-1 · Paper page
- 10.1016/S0387-7604(03)90012-X · DOI · Paper page
- 10.1177/08830738060210080901 · DOI
- 10.1212/01.wnl.0000217916.00225.3a · DOI · Paper page
- 10.1016/S0028-3908(01)00185-X · DOI
- 10.1038/sj.bjp.0704766 · DOI · Paper page
- 10.1002/mds.20385 · DOI
- Awaad YM, A, 2005, Long‐term follow‐up use of levetiracetam to treat tics in children, Ann Neurol, 58, S112
- Peterson BS, 1998, The treatment of Tourette's syndrome: multimodal, developmental intervention, J Clin Psychiatry, 59, 62
- Dure LSt, 2006, Treatment of tics, Adv Neurol, 99, 191
- 10.1177/088307380201700603 · doi:10.1177/088307380201700603
- 10.1097/00004583-198907000-00015 · DOI · Paper page
- 10.1037/0022-006X.61.3.506 · doi:10.1037/0022-006x.61.3.506 · Paper page
- 10.1542/peds.87.4.519 · DOI · Paper page
- 10.1097/00004583-199704000-00019 · DOI · Paper page
- Kovacs M, 1985, The Children's Depression, Inventory (CDI), Psychopharmacol Bull, 21, 995
- 10.1001/archneur.1993.00540100012008 · DOI · Paper page
- 10.2307/2531248 · DOI · Paper page
- 10.1016/j.eplepsyres.2005.10.006 · doi:10.1016/j.eplepsyres.2005.10.006
- 10.1097/00004583-199205000-00013 · DOI · Paper page
- 10.1016/0006-3223(93)90232-3 · DOI
Cited by
the ESSTS Guidelines Group, Roessner, V., Plessen, K. J., Rothenberger, A., Ludolph, A. G., Rizzo, R., Skov, L., Strand, G., Stern, J. S., Termine, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-011-0163-7 · Cited by 461
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders
Murphy, T. K., Lewin, A. B., Storch, E. A., & Stock, S. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.015 · Cited by 276
Treatment strategies for tics in Tourette syndrome
Eddy, C. M., Rickards, H. E., & Cavanna, A. E. (2011) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285610390261 · Cited by 158
Prenatal stress and inhibitory neuron systems: implications for neuropsychiatric disorders
Fine, R., Zhang, J., & Stevens, H. E. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.35 · Cited by 96
Metadata
- Authors
- Smith‐Hicks, C. L., Bridges, D. D., Paynter, N. P., & Singer, H. S.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2007-06-12
- Volume
- 22
- Issue
- 12
- Pages
- 1764-1770
- ISSN
- 0885-3185
- 1531-8257
- Cited by
- 71
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A double blind randomized placebo control trial of levetiracetam in tourette syndrome. https://app.cochat.ai/papers/10.1002/mds.21615
- The paper
- Smith‐Hicks, C. L., Bridges, D. D., Paynter, N. P., & Singer, H. S. (2007). A double blind randomized placebo control trial of levetiracetam in tourette syndrome. Movement Disorders. https://doi.org/10.1002/mds.21615
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.